KR100836861B1 - Feed composition for animal - Google Patents
Feed composition for animal Download PDFInfo
- Publication number
- KR100836861B1 KR100836861B1 KR1020030014403A KR20030014403A KR100836861B1 KR 100836861 B1 KR100836861 B1 KR 100836861B1 KR 1020030014403 A KR1020030014403 A KR 1020030014403A KR 20030014403 A KR20030014403 A KR 20030014403A KR 100836861 B1 KR100836861 B1 KR 100836861B1
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- feed composition
- animal feed
- animal
- mineral
- Prior art date
Links
- 241001465754 Metazoa Species 0.000 title claims abstract description 33
- 239000000203 mixture Substances 0.000 title claims abstract description 25
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 27
- 239000011707 mineral Substances 0.000 claims abstract description 27
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 21
- 235000015170 shellfish Nutrition 0.000 claims abstract description 13
- 235000015097 nutrients Nutrition 0.000 claims abstract description 7
- 241000209140 Triticum Species 0.000 claims abstract description 5
- 235000021307 Triticum Nutrition 0.000 claims abstract description 5
- 241000124008 Mammalia Species 0.000 claims abstract 2
- MJVAVZPDRWSRRC-UHFFFAOYSA-N Menadione Chemical compound C1=CC=C2C(=O)C(C)=CC(=O)C2=C1 MJVAVZPDRWSRRC-UHFFFAOYSA-N 0.000 claims description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 8
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 6
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 6
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 claims description 6
- 241000238366 Cephalopoda Species 0.000 claims description 4
- 229920001353 Dextrin Polymers 0.000 claims description 4
- 239000004375 Dextrin Substances 0.000 claims description 4
- 235000019733 Fish meal Nutrition 0.000 claims description 4
- 108010010803 Gelatin Proteins 0.000 claims description 4
- 241000442132 Lactarius lactarius Species 0.000 claims description 4
- -1 MgSO 4 7H 2 O Inorganic materials 0.000 claims description 4
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 4
- 235000019764 Soybean Meal Nutrition 0.000 claims description 4
- 239000011575 calcium Substances 0.000 claims description 4
- 235000014633 carbohydrates Nutrition 0.000 claims description 4
- 150000001720 carbohydrates Chemical class 0.000 claims description 4
- 235000019425 dextrin Nutrition 0.000 claims description 4
- 239000004467 fishmeal Substances 0.000 claims description 4
- 235000013312 flour Nutrition 0.000 claims description 4
- 239000008273 gelatin Substances 0.000 claims description 4
- 229920000159 gelatin Polymers 0.000 claims description 4
- 235000019322 gelatine Nutrition 0.000 claims description 4
- 235000011852 gelatine desserts Nutrition 0.000 claims description 4
- 150000002632 lipids Chemical class 0.000 claims description 4
- 210000004185 liver Anatomy 0.000 claims description 4
- 108090000623 proteins and genes Proteins 0.000 claims description 4
- 102000004169 proteins and genes Human genes 0.000 claims description 4
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 4
- 239000011780 sodium chloride Substances 0.000 claims description 4
- 239000004455 soybean meal Substances 0.000 claims description 4
- 235000012711 vitamin K3 Nutrition 0.000 claims description 4
- 239000011652 vitamin K3 Substances 0.000 claims description 4
- 229940041603 vitamin k 3 Drugs 0.000 claims description 4
- FAPWYRCQGJNNSJ-UHFFFAOYSA-L Calcium DL-pantothenate Chemical compound [Ca+2].OCC(C)(C)C(O)C(=O)NCCC([O-])=O.OCC(C)(C)C(O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UHFFFAOYSA-L 0.000 claims description 3
- 239000004151 Calcium iodate Substances 0.000 claims description 3
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims description 3
- 239000011626 DL-alpha-tocopherylacetate Substances 0.000 claims description 3
- 235000001809 DL-alpha-tocopherylacetate Nutrition 0.000 claims description 3
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims description 3
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 3
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 3
- 235000010323 ascorbic acid Nutrition 0.000 claims description 3
- 229960005070 ascorbic acid Drugs 0.000 claims description 3
- 239000011668 ascorbic acid Substances 0.000 claims description 3
- 229960002685 biotin Drugs 0.000 claims description 3
- 235000020958 biotin Nutrition 0.000 claims description 3
- 239000011616 biotin Substances 0.000 claims description 3
- 229910052791 calcium Inorganic materials 0.000 claims description 3
- UHWJJLGTKIWIJO-UHFFFAOYSA-L calcium iodate Chemical compound [Ca+2].[O-]I(=O)=O.[O-]I(=O)=O UHWJJLGTKIWIJO-UHFFFAOYSA-L 0.000 claims description 3
- 235000019390 calcium iodate Nutrition 0.000 claims description 3
- 229960001231 choline Drugs 0.000 claims description 3
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims description 3
- 229960000304 folic acid Drugs 0.000 claims description 3
- 235000019152 folic acid Nutrition 0.000 claims description 3
- 239000011724 folic acid Substances 0.000 claims description 3
- 229960000367 inositol Drugs 0.000 claims description 3
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims description 3
- 229960003512 nicotinic acid Drugs 0.000 claims description 3
- 235000001968 nicotinic acid Nutrition 0.000 claims description 3
- 239000011664 nicotinic acid Substances 0.000 claims description 3
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 claims description 3
- 229960000342 retinol acetate Drugs 0.000 claims description 3
- 235000019173 retinyl acetate Nutrition 0.000 claims description 3
- 239000011770 retinyl acetate Substances 0.000 claims description 3
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims description 3
- 229940042585 tocopherol acetate Drugs 0.000 claims description 3
- 229940088594 vitamin Drugs 0.000 claims description 3
- 229930003231 vitamin Natural products 0.000 claims description 3
- 235000013343 vitamin Nutrition 0.000 claims description 3
- 239000011782 vitamin Substances 0.000 claims description 3
- 229940011671 vitamin b6 Drugs 0.000 claims description 3
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 2
- 235000016709 nutrition Nutrition 0.000 claims description 2
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 claims description 2
- 239000011764 pyridoxine hydrochloride Substances 0.000 claims description 2
- 229960002477 riboflavin Drugs 0.000 claims description 2
- 235000019192 riboflavin Nutrition 0.000 claims description 2
- 239000002151 riboflavin Substances 0.000 claims description 2
- 229960004860 thiamine mononitrate Drugs 0.000 claims description 2
- 235000019191 thiamine mononitrate Nutrition 0.000 claims description 2
- 239000011748 thiamine mononitrate Substances 0.000 claims description 2
- UIERGBJEBXXIGO-UHFFFAOYSA-N thiamine mononitrate Chemical compound [O-][N+]([O-])=O.CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N UIERGBJEBXXIGO-UHFFFAOYSA-N 0.000 claims description 2
- 239000000654 additive Substances 0.000 claims 4
- 230000000996 additive effect Effects 0.000 claims 3
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 claims 1
- 239000004816 latex Substances 0.000 claims 1
- 229920000126 latex Polymers 0.000 claims 1
- 229940091348 latex Drugs 0.000 claims 1
- 241000251468 Actinopterygii Species 0.000 abstract description 11
- 238000009395 breeding Methods 0.000 abstract description 8
- 230000001488 breeding effect Effects 0.000 abstract description 8
- 230000000694 effects Effects 0.000 abstract description 8
- 238000009360 aquaculture Methods 0.000 abstract description 7
- 244000144974 aquaculture Species 0.000 abstract description 7
- 201000010099 disease Diseases 0.000 abstract description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 6
- 208000035240 Disease Resistance Diseases 0.000 abstract description 5
- 244000144972 livestock Species 0.000 abstract description 5
- 241000269908 Platichthys flesus Species 0.000 abstract description 4
- 241000283690 Bos taurus Species 0.000 abstract description 3
- 241000287828 Gallus gallus Species 0.000 abstract description 3
- 230000009471 action Effects 0.000 abstract description 3
- 235000013330 chicken meat Nutrition 0.000 abstract description 3
- 230000036039 immunity Effects 0.000 abstract description 3
- 230000015788 innate immune response Effects 0.000 abstract description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 3
- 241000282887 Suidae Species 0.000 abstract description 2
- 230000002411 adverse Effects 0.000 abstract description 2
- 230000007423 decrease Effects 0.000 abstract description 2
- 235000013372 meat Nutrition 0.000 abstract description 2
- 238000000746 purification Methods 0.000 abstract description 2
- KKCBUQHMOMHUOY-UHFFFAOYSA-N Na2O Inorganic materials [O-2].[Na+].[Na+] KKCBUQHMOMHUOY-UHFFFAOYSA-N 0.000 abstract 1
- 238000002474 experimental method Methods 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 6
- 230000001965 increasing effect Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 241000607471 Edwardsiella tarda Species 0.000 description 3
- 239000003674 animal food additive Substances 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 238000009313 farming Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000007928 intraperitoneal injection Substances 0.000 description 3
- 239000011435 rock Substances 0.000 description 3
- 235000014102 seafood Nutrition 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 239000006150 trypticase soy agar Substances 0.000 description 3
- 229910018072 Al 2 O 3 Inorganic materials 0.000 description 2
- 235000019750 Crude protein Nutrition 0.000 description 2
- 229910004298 SiO 2 Inorganic materials 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 230000001186 cumulative effect Effects 0.000 description 2
- 239000010433 feldspar Substances 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- 239000005995 Aluminium silicate Substances 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241000269979 Paralichthys olivaceus Species 0.000 description 1
- 208000030852 Parasitic disease Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 238000000540 analysis of variance Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 235000019784 crude fat Nutrition 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 238000013401 experimental design Methods 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910052900 illite Inorganic materials 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N iron oxide Inorganic materials [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 238000006241 metabolic reaction Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000011785 micronutrient Substances 0.000 description 1
- 235000013369 micronutrients Nutrition 0.000 description 1
- 239000008239 natural water Substances 0.000 description 1
- VGIBGUSAECPPNB-UHFFFAOYSA-L nonaaluminum;magnesium;tripotassium;1,3-dioxido-2,4,5-trioxa-1,3-disilabicyclo[1.1.1]pentane;iron(2+);oxygen(2-);fluoride;hydroxide Chemical compound [OH-].[O-2].[O-2].[O-2].[O-2].[O-2].[F-].[Mg+2].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[K+].[K+].[K+].[Fe+2].O1[Si]2([O-])O[Si]1([O-])O2.O1[Si]2([O-])O[Si]1([O-])O2.O1[Si]2([O-])O[Si]1([O-])O2.O1[Si]2([O-])O[Si]1([O-])O2.O1[Si]2([O-])O[Si]1([O-])O2.O1[Si]2([O-])O[Si]1([O-])O2.O1[Si]2([O-])O[Si]1([O-])O2 VGIBGUSAECPPNB-UHFFFAOYSA-L 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- NDLPOXTZKUMGOV-UHFFFAOYSA-N oxo(oxoferriooxy)iron hydrate Chemical compound O.O=[Fe]O[Fe]=O NDLPOXTZKUMGOV-UHFFFAOYSA-N 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 210000002820 sympathetic nervous system Anatomy 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
- A23K20/22—Compounds of alkali metals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/105—Aliphatic or alicyclic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
- A23K20/147—Polymeric derivatives, e.g. peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/174—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/163—Sugars; Polysaccharides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/80—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in fisheries management
- Y02A40/81—Aquaculture, e.g. of fish
- Y02A40/818—Alternative feeds for fish, e.g. in aquacultures
Abstract
본 발명은 동물 사료 조성물에 관한 것으로서, 이 동물 사료 조성물은 Na2O 및 K2O을 포함하는 광물 및 영양원을 포함한다. Na2O 및 K2O의 함량은 광물 중량에 대하여 Na2O 2 내지 6 중량%, K2O 2 내지 10 중량% 이며, 전체 동물 사료 중량에 대하여는 Na2O는 0.1 내지 3 중량%이고, K2O는 0.1 내지 3 중량%이다. 상기 동물 사료 조성물은 넙치 등의 어패류뿐만 아니라 닭, 소 또는 돼지 등의 포유류를 양식하는데 사용할 수 있다.The present invention relates to an animal feed composition, the animal feed composition comprising minerals and nutrients, including Na 2 O and K 2 O. The content of Na 2 O and K 2 O is Na 2 O 2 to 6% by weight, K 2 O 2 to 10% by weight based on the weight of the mineral, Na 2 O is 0.1 to 3% by weight based on the total animal feed weight, K 2 O is 0.1 to 3% by weight. The animal feed composition can be used to culture mammals such as chickens, cattle or pigs as well as fish and shellfish such as flounder.
상기 동물 사료 조성물은 급속한 양식업 및 사육업의 팽창과 더불어 고밀도 사육과 같은 문제로 인해 생산성 저하 및 질병이 빈번하게 발생하고 있는 국내 양식 산업에 성장과 사료 효율에 악영향을 끼치지 않고 동물의 비특이적 면역 반응을 증강시켜 생산성 향상 및 어패류 밀 동물의 질병을 예방할 수 있다. 또한, 본 발명의 사료 조성물이 면역 증대에 큰 효과가 있으므로 어린 동물의 미립자 사료로 더 효과적으로 사용할 수 있다. 따라서, 본 발명의 사료 조성물은 어패류 및 가축 등 동물의 육질 개선과 내병성 증대에 큰 효과를 나타낼 수 있으며, 또한 어패류 양식에 사용할 경우 수질 정화 작용에 큰 효과를 나타낼 수 있다.The animal feed composition is a non-specific immune response of the animal without adversely affecting growth and feed efficiency in the domestic aquaculture industry where productivity decreases and diseases frequently occur due to problems such as rapid aquaculture and breeding, and high density breeding. To increase productivity and prevent disease of shellfish wheat animals. In addition, since the feed composition of the present invention has a great effect on boosting immunity, it can be used more effectively as a particulate feed of a young animal. Therefore, the feed composition of the present invention can exhibit a great effect on improving the meat quality and disease resistance of animals such as shellfish and livestock, and can also have a great effect on the water purification action when used in aquaculture.
동물사료, Na2O, K2OAnimal Feed, Na2O, K2O
Description
도 1은 본 발명의 실시예 1 내지 3 및 비교예 1의 사료를 투여하여 양식한 넙치의 질병 저항성을 나타내는 그래프. 1 is a graph showing the disease resistance of the flounder cultured by administering the feed of Examples 1 to 3 and Comparative Example 1 of the present invention.
[산업상 이용 분야][Industrial use]
본 발명은 동물 사료 조성물에 관한 것으로서, 보다 상세하게는 생체 발육과 생리 기능을 조절하여 세포 활력을 우수하게 유지하고 면역 강화 효과가 우수한 동물 사료 조성물에 관한 것이다.The present invention relates to an animal feed composition, and more particularly, to an animal feed composition that maintains cell vitality and regulates an immune enhancing effect by regulating biological growth and physiological function.
[종래 기술][Prior art]
국내 대부분의 어패류 양식 산업은 현재 급속하게 팽창하고 있는 추세이다. 그러나 양식 어패류의 종묘 생산 및 양성 과정에 있어서 고밀도 사육과 영양 공급의 불균형과 같은 문제로 인하여 생산성 저하 및 수많은 세균성 질병, 바이러스성 질병 및 기생충성 질병의 발생은 커다란 문제로 대두되고 있어 막대한 경제적 손실을 초래하고 있다.Most of the domestic seafood industry is expanding rapidly. However, productivity problems and the incidence of numerous bacterial, viral and parasitic diseases due to problems such as high density breeding and nutritional imbalances in the production and cultivation of cultured fish and shellfish have become a huge problem, leading to enormous economic losses. It is causing.
특히, 양식 어패류의 질병 대책으로서는 미연 방지보다 질병 발생 후에 항생 제 및 여러 종류의 화학 약품을 사용하고 있으며, 이와 같은 약제의 남용으로 어패류에게 스트레스를 주어 면역 반응을 감소시킬 뿐만 아니라 환경 오염 및 병원체의 내성 증가 문제와 나아가서는 인체에도 영향을 줄 수 있는 가능성 등 많은 문제점을 가지고 있다. 이에 국내에서는 성장 촉진 및 사료 효율을 개선하거나 어패류의 비특이적 면역 반응 및 항산화능을 증강시켜 생산성 향상 및 양식 어패류의 질병을 예방할 수 있는 사료 첨가제의 현장 수요가 급증하고 있다.In particular, as a countermeasure for aquaculture and shellfish, antibiotics and various types of chemicals are used after disease occurrence, rather than prevention, and the abuse of such drugs causes stress on fish and shellfish to reduce the immune response, as well as to reduce environmental pollution and pathogens. There are many problems such as increased resistance and the possibility of affecting the human body. In Korea, the demand for feed additives that can improve the productivity and prevent disease of farmed fish and shellfish is increasing rapidly by promoting growth and improving feed efficiency, or by enhancing the non-specific immune response and antioxidant capacity of fish and shellfish.
이러한 사료 첨가제로 맥반석(bio stone)이 연구되고 있다. 맥반석은 화성암 중 석영암반에 속하는 암석으로 무수규산과 산화 알루미늄이 주성분이고, 그 외에도 인체 및 생물에 필요한 산화 제 2 철, 칼슘, 마그네슘, 게르마늄, 세레늄 등 약 40여종의 미네랄로 구성되어 있다. 상기 맥반석의 생체 효과로는 크게 3가지로 나눌 수 있는데 첫 번째로 맥반석 표면과 내부의 무수한 미세 구멍이 모세관 현상을 일으켜 카드뮴, 수은 등의 중금속과 같은 유해 물질을 흡착, 분해, 제거하는 효과가 있으며, 두 번째로 원적외선을 방출하여 생체내 세포를 활성화시키며, 신진대사 및 혈액순환을 도와 체내의 노폐물 및 유해 물질의 배출을 원활하게 한다. 세 번째로 맥반석의 미네랄 성분(약 40여종)은 생체에 필수적이면서 결핍되기 쉬운 미량 영양소(무기질)를 충분히 공급하여 성장을 촉진시키고, 인체 및 생물체의 발육과 생리 기능을 조절하며 정상적인 생명력을 유지하는 등 여러 가지 대사 작용을 원활하게 해준다. Biostones are being studied as such feed additives. Elvanite is a rock belonging to quartz rock among igneous rocks. It is composed mainly of silicic anhydride and aluminum oxide, and is composed of about 40 kinds of minerals such as ferric oxide, calcium, magnesium, germanium, and selenium which are necessary for human body and living organisms. Bioavailability of the elvan can be divided into three types. First, numerous micropores on the surface and inside of the elvan cause capillary action, which is effective in adsorbing, decomposing and removing harmful substances such as heavy metals such as cadmium and mercury. Second, it activates cells in vivo by releasing far-infrared rays, helping metabolism and blood circulation to facilitate the discharge of waste and harmful substances in the body. Thirdly, the mineral component (about 40 kinds) of elvan is sufficient to supply micronutrients (minerals) which are essential to the living body and are easily deficient, to promote growth, to regulate the growth and physiology of the human body and living organisms, and to maintain normal vitality. It also facilitates various metabolic reactions.
또한 이러한 사료 첨가제로는 어패류 양식 뿐만 아니라, 닭, 소, 돼지 등 가축 사료에 대해서도 활발하게 연구되고 있다.In addition, such feed additives have been actively researched not only for fish and shellfish farming but also for livestock feed such as chicken, cow, and pig.
본 발명은 상술한 문제점을 해결하기 위한 것으로서, 본 발명의 목적은 생체 발육과 생리 기능을 조절하여 세포 활력을 우수하게 유지하고 면역력 강화 효과가 우수한 동물 사료 조성물을 제공하는 것이다.The present invention is to solve the above problems, an object of the present invention is to provide an animal feed composition excellent in maintaining the cell vitality and excellent immunity enhancing effect by regulating the growth and physiological function.
상기 목적을 달성하기 위하여, 본 발명은 Na2O 및 K2O을 포함하는 광물; 및 영양원을 포함하며, 상기 Na2O 및 K2O의 함량은 상기 광물 중량에 대하여 Na 2O 2 내지 6 중량%, K2O 2 내지 10 중량%인 동물 사료 조성물을 제공한다.In order to achieve the above object, the present invention is a mineral containing Na 2 O and K 2 O; And a nutrient source, wherein the content of Na 2 O and K 2 O provides animal feed compositions of Na 2 O 2 to 6% by weight and K 2 O 2 to 10% by weight based on the weight of the mineral.
이하 본 발명을 보다 상세하게 설명한다.Hereinafter, the present invention will be described in more detail.
본 발명은 동물 사료 조성물에 관한 것으로서, 이 사료 조성물은 Na2O 및 K2O를 포함하는 광물을 포함하며, Na2O 및 K2O의 함량은 전체 광물 중량에 대하여 각각 2 내지 6 중량%, 2 내지 10 중량%가 바람직하며, 이때 Na2O 및 K2O의 전체 함량은 4 중량%를 초과하고 15 중량% 이하가 바람직하고, 6 내지 12 중량%가 보다 바람직하다. 또한, 전체 동물 사료 조성물 중량에 대하여는 Na2O의 함량은 0.1 내지 3 중량%가 바람직하고, 보다 바람직하게는 0.2 내지 1 중량%, 가장 바람직하게는 0.5 중량%이며, K2O의 함량은 0.1 내지 3 중량%가 바람직하고, 보다 바람직하게는 0.2 내지 1.2, 가장 바람직하게는 0.1 내지 0.5 중량%이다. The present invention relates to an animal feed composition, the feed composition comprises Na 2 O and a mineral containing K 2 O, Na 2 content of O and K 2 O are each 2 to 6% by weight based on the total mineral weight , 2 to 10% by weight is preferred, wherein the total content of Na 2 O and K 2 O is more than 4% by weight, preferably 15% by weight or less, and more preferably 6 to 12% by weight. In addition, the content of Na 2 O is preferably 0.1 to 3% by weight, more preferably 0.2 to 1% by weight, most preferably 0.5% by weight, and K 2 O based on the total weight of the animal feed composition. To 3% by weight is preferred, more preferably 0.2 to 1.2 and most preferably 0.1 to 0.5% by weight.
Na2O 및 K2O는 질병 예방과 치료, 살균 작용, 체내 해독, 교감 신경계의 억제 작용, 생육 촉진, 수확량 증가 등의 효과를 동물 사료에 부여할 수 있다. 상기 Na2O 및 K2O 중 하나의 최소 함량은 2 중량%여도 무방하나, Na2O 및 K 2O이 둘다 2 중량%로, 전체 함량이 전체 광물 중량에 대하여 4 중량% 이하가 되는 경우에는 수확량 저하, 살균작용 저하, 치료효과 저하의 문제점이 있다. Na 2 O and K 2 O can impart effects to the animal feed such as disease prevention and treatment, bactericidal action, detoxification in the body, inhibition of the sympathetic nervous system, promotion of growth and increased yield. The minimum content of one of Na 2 O and K 2 O may be 2% by weight, but both Na 2 O and K 2 O are 2% by weight, and the total content is 4% by weight or less based on the total mineral weight. There is a problem of reduced yield, lower sterilization, lower treatment effect.
또한, Na2O의 함량이 전체 광물 중량에 대하여 5 중량%를 초과하는 경우에는 과다한 살균작용에 문제점이 있고, 상기 K2O의 함량이 전체 광물 중량에 대하여 10 중량%를 초과하는 경우에는 과다 수확량 증가로 인한 균형의 파괴에 문제점이 있다.In addition, when the content of Na 2 O exceeds 5% by weight relative to the total mineral weight, there is a problem in excessive sterilization, and when the content of K 2 O exceeds 10% by weight based on the total mineral weight, There is a problem with the breakdown of balance due to increased yield.
본 발명의 동물 사료에 사용되는 광물로는 Na2O 및 K2O를 상술한 범위의 양으로 포함하고, 동물에게 유해한 독성을 갖지 않는 고령토, 규조토, 납석, 일라이트 또는 장석을 사용한다. 상기 광물은 Na2O 및 K2O 이외에 SiO2, Al 2O3, Fe2O3, CaO, MgO 등을 포함하며, 이들의 함량은 본 발명에 있어서 중요한 값이 아니므로 굳이 한정할 필요는 없다.Minerals used in the animal feed of the present invention include kaolin, diatomaceous earth, feldspar, illite or feldspar, which contain Na 2 O and K 2 O in an amount in the above-mentioned range and which do not have harmful toxicity to animals. The minerals include SiO 2 , Al 2 O 3 , Fe 2 O 3 , CaO, MgO, etc. in addition to Na 2 O and K 2 O, and their contents are not important values in the present invention, so they need to be limited. none.
본 발명의 동물 사료에서 영양원은 각 동물의 종류에 따라 적절하게 변경시킬 수 있으며, 이는 당해 분야에서 널리 이해될 수 있음이 명백하다. 그 예로 어패류 양식에 급여할 경우, 상기 영양원은 단백질원으로 북양어분(white fish meal), 젤라틴(gelatin), 탈피대두박(dehulled soybean meal) 등을 사용할 수 있으 며, 탄수화물원으로는 밀가루(wheat flour)와 덱스트린(dextrin)을, 지질원으로는 고도불포화 지방산이 다량 함유된 오징어 간유(squid liver oil) 등을 포함할 수 있다. 또한 이외에도 아스코르브산, dl-칼슘 판토티네이트(dl-calcium pantothenate), 콜린 바이타트레이트(choline bitatrate), 이노시톨(inositol), 메나디온(menadione), 니아신(niacin), 피리독신·HCl, 리보플라빈, 티아민 모노나이트레이트, dl-α-토코페롤 아세테이트, 레티닐 아세테이트, 비오틴, 폴릭산(folic acid), B12 등과 같은 비타민, NaCl, MgSO4·7H2O, NaH2P 4 2H2O, Ca(H2PO4)2·2H2O, KH2PO4, ZnSO4·7H2O, Fe-시트레이트, Ca-락테이트, MnSO 4, FeSO4, CuSO4, 칼슘 이오데이트, MgO, NaSeO3 등과 같은 무기질을 포함할 수도 있다.In the animal feed of the present invention, the nutrient source can be appropriately modified according to the type of each animal, which is obviously widely understood in the art. For example, when feeding fish and shellfish farming, the nutrient source may include white fish meal, gelatin, dehulled soybean meal as protein sources, and wheat flour as a carbohydrate source. ) And dextrin, and squid liver oil containing a large amount of polyunsaturated fatty acids may be included as a lipid source. In addition, ascorbic acid, dl-calcium pantothenate, choline bitatrate, inositol, menadione, niacin, pyridoxine / HCl, riboflavin, thiamine Vitamins such as mononitrate, dl-α-tocopherol acetate, retinyl acetate, biotin, folic acid, B 12, etc., NaCl, MgSO 4 .7H 2 O, NaH 2 P 4 2H 2 O, Ca (H 2 PO 4 ) 2 · 2H 2 O, KH 2 PO 4 , ZnSO 4 · 7H 2 O, Fe-citrate, Ca-lactate, MnSO 4 , FeSO 4 , CuSO 4 , Calcium Iodate, MgO, NaSeO 3, etc. It may also contain the same minerals.
본 명세서에서 "동물"이라함은 어패류, 가축 등 모두 포함하는 것이다. 상기 동물 사료는 넙치 등의 어패류를 양식할 때 급여하거나 또는 돼지, 소, 닭 등의 가축을 사육할 때 급여할 수 있으며, 이에 한정되는 것은 아니다. As used herein, the term "animal" is intended to include both seafood and livestock. The animal feed may be fed when farming seafood such as flounder or when breeding livestock such as pigs, cows, and chickens, but is not limited thereto.
이하 본 발명의 바람직한 실시예 및 비교예를 기재한다. 그러나 하기한 실시예는 본 발명의 바람직한 일 실시예일 뿐 본 발명이 하기한 실시예에 한정되는 것은 아니다.Hereinafter, preferred examples and comparative examples of the present invention are described. However, the following examples are only one preferred embodiment of the present invention and the present invention is not limited to the following examples.
1) 실험어1) Experimental word
넙치를 2톤 원형 수조에서 실험 환경에 적응할 수 있도록 2주간 예비사육 하였다. 예비 사육후, 평균 무게 5.0±0.04g(평균±표준 편차)인 넙치를 40ℓ 사각 수조 4개에 각각 25마리씩 3반복으로 무작위 배치하였다. 각 실험 수조는 유수식 으로 유수량은 1 내지 2ℓ/분으로 조절하여 주었다. 충분한 산소 공급을 위해 에어스톤을 설치하였으며, 실험 기간 동안 평균 수온은 17 내지 22℃로 전 실험 기간 동안 자연 수온에 의존하였다. 일일 사료 공급량은 전 실험 기간 동안 1일 2회 어체중의 4 내지 5%(오전 10시, 오후 4시)로 공급하였으며 주 사육 실험 기간은 8주간 실시하였다.Olive flounder was pre-cultured for 2 weeks to adapt to the experimental environment in a 2 ton round tank. After preliminary breeding, the flounder, with an average weight of 5.0 ± 0.04 g (mean ± standard deviation), was randomly placed in three replicates of 25 animals in four 40 L square tanks. Each experimental tank was flow-through, and the flow rate was adjusted to 1 to 2 l / min. Airstone was installed for sufficient oxygen supply and the average water temperature during the experiment period was 17-22 ° C. dependent on the natural water temperature for the entire experiment period. The daily feeding amount was supplied at 4-5% (10 am, 4 pm) of fish weight twice a day during the entire experiment period, and the main breeding experiment was conducted for 8 weeks.
2) 실험 사료 및 실험 설계2) experimental feed and experimental design
실험에 사용된 실험 사료의 조성표와 사료에 포함되어 있는 일반 성분은 표 1에 나타내었다. 실험 사료의 단백질원으로 북양어분(white fish meal), 젤라틴(gelatin), 탈피대두박(dehulled soybean meal)을 사용하였으며, 탄수화물원으로는 밀가루(wheat flour)와 덱스트린(dextrin)을, 지질원으로는 고도불포화 지방산(n-3 HUFA)이 다량 함유된 오징어간유(squid liver oil)를 사용하였다. The composition table of the experimental feed used in the experiment and the general components included in the feed are shown in Table 1. White fish meal, gelatin, and dehulled soybean meal were used as protein sources of the experimental feed.Wheat flour and dextrin were used as carbohydrate sources, and as lipid sources. Squid liver oil containing a large amount of polyunsaturated fatty acid (n-3 HUFA) was used.
Na2O 3.5 중량%, K2O 5.02 중량%, SiO2 73.5 중량%, Al2O 3 15.3 중량%, Fe2O3 0.5 중량%, CaO 0.56 중량%, MgO 0.06 중량%, 강열 감량(ignition loss) 1.09 중량% 및 나머지 미량 성분을 포함하는 광물을 실험 사료 내에 각각 0 중량%(비교예 1), 0.5 중량%(실시예 1), 1 중량%(실시예 2) 및 2 중량%(실시예 3) 첨가하였다. Na 2 O 3.5 wt%, K 2 O 5.02 wt%, SiO 2 73.5 wt%, Al 2 O 3 15.3 wt%, Fe 2 O 3 0.5 wt%, CaO 0.56 wt%, MgO 0.06 wt%, Ignition loss (ignition loss) Minerals containing 1.09% by weight and the remaining trace components were respectively added to 0% by weight (Comparative Example 1), 0.5% by weight (Example 1), 1% by weight (Example 2) and 2% by weight (test Example 3) was added.
실험 사료의 조단백질 함량은 50.0%, 가용에너지는 16.7kJ/g(단백질, 16.7kJ/g); 지질, 37.7kJ/g; 탄수화물, 16.7kJ/g)으로 조절하였다(NRC, 1993). 그리고 각 실험 사료별 광물의 첨가량에 따른 가용 에너지의 차이는 셀룰로오스(cellulose)를 첨가하여 동일하게 맞추어 주었다. 광물은 미세한 분말로 제조하여 사용하였다. 모든 실험 사료는 원료를 혼합한 후 펠렛 제조기로 압출·성형하였으며, 강제 통풍식 건조기로 건조(15℃, 24시간)시킨 다음 실험어의 크기에 맞도록 입자 크기를 500㎛와 1,000㎛ 표준체(sieve)를 이용하여 고르게 친 후, 밀봉하여 -20℃에 냉동 보관하면서 사용하였다.Crude protein content of experimental feed was 50.0%, and available energy was 16.7kJ / g (protein, 16.7kJ / g); Lipid, 37.7 kJ / g; Carbohydrates, 16.7 kJ / g) (NRC, 1993). The difference in available energy according to the amount of minerals added to each experimental feed was equally adjusted by adding cellulose. Minerals were prepared and used as fine powder. All experimental feeds were mixed with raw materials and then extruded and molded into a pellet maker, dried with a forced draft dryer (15 ° C. for 24 hours), and then particle size was 500 μm and 1,000 μm standard (sieve). ) And then evenly sealed, and used while being frozen and stored at -20 ° C.
1, 2 수협 1, 2 strait
3 미국 대두 협회 3 American Soybean Association
4 영남제분 4 Youngnam Mills
5, 10 United States Biochemical, Cleveland, Ohio, 44122 5, 10 United States Biochemical, Cleveland, Ohio, 44122
7 이화유지 7 Ewha Maintenance
8 성분, 사료 중의 함량(mg/kg): 아스코르브산, 300; dl-칼슘 판토티네이트(dl-Calcium pantothenate), 150; 콜린 바이타트레이트(Choline bitatrate), 3000; 이노시톨(Inositol), 150; 메나디온(Menadione), 6; 니아신(Niacin), 150, 피리독신·HCl(Pyridoxine·HCl), 15; 피로플라빈, 30; 티아민 모노니트레이트(Thiamine mononitrate), 15; dl-α-토코페롤 아세테이트, 201; 레티닐 아세테이트, 6; 비오틴, 1.5; 폴린산, 5.4; B12, 0.06 8 ingredients, feed content (mg / kg): ascorbic acid, 300; dl-Calcium pantothenate, 150; Choline bitatrate, 3000; Inositol, 150; Menadione, 6; Niacin, 150, pyridoxine HCl, 15; Pyroflavin, 30; Thiamine mononitrate, 15; dl-α-tocopherol acetate, 201; Retinyl acetate, 6; Biotin, 1.5; Folic acid, 5.4; B 12 , 0.06
9 성분, 사료 중의 함량(mg/kg): NaCl, 437.4; MgSO4·7H2O, 1379.8; NaH 2P4 2H2O, 877.8; Ca(H2PO4)2·2H2O, 1366.7, KH 2PO4, 2414; ZnSO4·7H2O, 226.4; Fe-시트레이트, 299; Ca-락테이트, 3004; MnSO4, 0.016; FeSO4, 0.0378; CuSO4 , 0.00033; 칼슘 이오데이트, 0.0006; MgO, 0.00135; NaSeO3, 0.00025 9 ingredients, feed content (mg / kg): NaCl, 437.4; MgSO 4 7H 2 O, 1379.8; NaH 2 P 4 2H 2 O, 877.8; Ca (H 2 PO 4 ) 2 .2H 2 O, 1366.7, KH 2 PO 4 , 2414; ZnSO 4 7H 2 O, 226.4; Fe-citrate, 299; Ca-lactate, 3004; MnSO 4 , 0.016; FeSO 4 , 0.0378; CuSO 4 , 0.00033; Calcium iodate, 0.0006; MgO, 0.00135; NaSeO 3 , 0.00025
* 통계 처리* Statistics processing
모든 자료의 통계 처리는 컴퓨터 프로그램 스타티스틱스(statistix) 3.1(Analytical Software, St. Paul MN. USA)로 분산분석(ANOVA test)을 실시하여 최소유의차 검정(LSD: Least Significant Difference)으로 평균간의 유의성(P < 0.05)을 검정하였다. Statistical processing of all data was carried out by ANOVA test with the computer program Statisix 3.1 (Analytical Software, St. Paul MN. USA) and Least Significant Difference (LSD). (P <0.05) was assayed.
3) 실험 결과3) Experiment result
① 공격실험① Attack experiment
A. 재료 및 방법A. Materials and Methods
독성이 있는 에드워드시엘라 타르다(Edwardsiella tarda) 부유액(1 × 106 cfu/ml)을 1.5% NaCl이 첨가된 트립티케이스 대두 배지(trypticase soy agar(TSA))에 27℃에서 48시간 배양하여 준비하였다. 어류당 박테리아 부유물을 0.1ml씩 복강 주사한 후 폐사를 기록하였다. 폐사어의 폐사원인을 확인하기 위해 매일 폐사된 어체로부터 신장을 채취하여 TSA에 배양하여 E. tarda의 존재를 확인하였다.Toxic Edwardsiella tarda suspension (1 × 10 6 cfu / ml) was incubated for 48 hours at 27 ° C. in trypticase soy agar (TSA) containing 1.5% NaCl. Ready. Death was recorded after intraperitoneal injection of 0.1 ml bacterial suspension per fish. To confirm the cause of mortality, kidneys were collected from the dead fish bodies and cultured in TSA to confirm the presence of E. tarda.
B. 결과B. Results
E. tarda FPC 799 균주로 복강 주사한 후 실험구별 누적 생존율을 조사하여 그 결과를 도 1에 나타내었다(P < 0.05). 도 1에 나타낸 것과 같이, 실시예 2 내지 3이 비교예 1에 비해서 누적 생존율이 높음을 알 수 있다. 복강 주사 후 4일째부터 폐사체가 나타나기 시작하였으며, 9 내지 10일 전후로 폐사율이 급증하였고, 13일 이후 폐사하는 개체는 없었다. 이는 본 발명의 광물을 첨가한 실시예 1은 비교예 1과 비교해 보았을 때 내병성(질병 저항성)이 더 강화되었다는 것을 의미한다. 또한, 이 결과에 따라, 본 발명의 광물이 원적외선을 방출하여 생체내 세포를 활성화시키며 신진 대사 및 혈액 순환을 도와 체내의 노폐물 유해 물질의 배출을 원활하게 해줌으로써 어류의 건강을 증진시키는 것으로 예측할 수 있다.After intraperitoneal injection with E. tarda FPC 799 strain, the cumulative survival rate of each experimental group was examined and the results are shown in FIG. 1 (P <0.05). As shown in FIG. 1, it can be seen that Examples 2 to 3 have a higher cumulative survival rate than Comparative Example 1. The mortality began to appear on day 4 after intraperitoneal injection, mortality spiked around 9-10 days, and no mortality occurred after 13 days. This means that Example 1, in which the mineral of the present invention was added, was further enhanced in disease resistance (disease resistance) when compared with Comparative Example 1. In addition, according to this result, it can be predicted that the mineral of the present invention promotes the health of fish by releasing far-infrared rays, activating cells in vivo, and helping metabolism and blood circulation to facilitate the discharge of waste harmful substances in the body. have.
본 발명의 Na2O 및 K2O를 특정 함량으로 포함하는 동물 사료 조성물은 급속한 양식업 및 사육업의 팽창과 더불어 고밀도 사육과 같은 문제로 인해 생산성 저하 및 질병이 빈번하게 발생하고 있는 국내 양식 산업에 성장과 사료 효율에 악영향을 끼치지 않고 동물의 비특이적 면역 반응을 증강시켜 생산성 향상 및 어패류 밀 동물의 질병을 예방할 수 있다. 또한, 본 발명의 사료 조성물이 면역 증대에 큰 효과가 있으므로 어린 동물의 미립자 사료로 더 효과적으로 사용할 수 있다. 따라서, 본 발명의 사료 조성물은 어패류 및 가축 등 동물의 육질 개선과 내병성 증대에 큰 효과를 나타낼 수 있으며, 또한 어패류 양식에 사용할 경우 수질 정화 작용에 큰 효과를 나타낼 수 있다.Animal feed composition comprising Na 2 O and K 2 O of the present invention in a specific content has been applied to the domestic aquaculture industry, where productivity decreases and diseases frequently occur due to problems such as high density breeding with rapid expansion of aquaculture and breeding. Enhancement of nonspecific immune responses in animals without adversely affecting growth and feed efficiency can improve productivity and prevent disease in shellfish wheat animals. In addition, since the feed composition of the present invention has a great effect on boosting immunity, it can be used more effectively as a particulate feed of a young animal. Therefore, the feed composition of the present invention can exhibit a great effect on improving the meat quality and disease resistance of animals such as shellfish and livestock, and can also have a great effect on the water purification action when used in aquaculture.
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020030014403A KR100836861B1 (en) | 2003-03-07 | 2003-03-07 | Feed composition for animal |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020030014403A KR100836861B1 (en) | 2003-03-07 | 2003-03-07 | Feed composition for animal |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20040079283A KR20040079283A (en) | 2004-09-14 |
KR100836861B1 true KR100836861B1 (en) | 2008-06-11 |
Family
ID=37364321
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020030014403A KR100836861B1 (en) | 2003-03-07 | 2003-03-07 | Feed composition for animal |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100836861B1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101334605B1 (en) | 2011-12-23 | 2013-11-29 | 한국식품연구원 | Diet Compositions For Measuring AME of Food, Manufacturing Method Of Food/Diet Compositions And AME Measuring Method Using The Same |
KR102527476B1 (en) * | 2021-12-24 | 2023-05-04 | 하선사료 주식회사 | Feed composition for promoting growth and manufacturing method thereof |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100767624B1 (en) * | 2007-02-06 | 2007-10-17 | 금산축산업협동조합 | Manufacturing method of ginseng leaves feed additives |
CN109588564A (en) * | 2018-11-27 | 2019-04-09 | 广州爱保农饲料有限公司 | A kind of milk cow vitamine premix and preparation method thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR970073370A (en) * | 1996-05-04 | 1997-12-10 | 이상징 | Method for constructing a feed additive composition using natural minerals |
KR20010035412A (en) * | 2000-07-31 | 2001-05-07 | 정연권 | Feed Composition of Growing Livestock for Replacing Antibiotics |
-
2003
- 2003-03-07 KR KR1020030014403A patent/KR100836861B1/en active IP Right Grant
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR970073370A (en) * | 1996-05-04 | 1997-12-10 | 이상징 | Method for constructing a feed additive composition using natural minerals |
KR20010035412A (en) * | 2000-07-31 | 2001-05-07 | 정연권 | Feed Composition of Growing Livestock for Replacing Antibiotics |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101334605B1 (en) | 2011-12-23 | 2013-11-29 | 한국식품연구원 | Diet Compositions For Measuring AME of Food, Manufacturing Method Of Food/Diet Compositions And AME Measuring Method Using The Same |
KR102527476B1 (en) * | 2021-12-24 | 2023-05-04 | 하선사료 주식회사 | Feed composition for promoting growth and manufacturing method thereof |
Also Published As
Publication number | Publication date |
---|---|
KR20040079283A (en) | 2004-09-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103734550B (en) | A kind of nursery pig concentrated feed | |
CN103250879B (en) | Compound feed for adjusting intestinal development of piglets, and application thereof | |
CN104095163B (en) | The special Chinese herbal feed of fattening period meat rabbit | |
CN103340308A (en) | Application of fibrauretine in cyprinus carpio compound feed and formula of cyprinus carpio compound feed containing fibrauretine | |
KR20200018997A (en) | Feed composition for Litopenaeus vannamei comprising Spirulina | |
Olusola et al. | Growth performance of Nile tilapia (Oreochromis niloticus) fed processed soybean meal based diets supplemented with phytase | |
CN108142688B (en) | Zinc oxide-free conservation material | |
KR100836861B1 (en) | Feed composition for animal | |
EP3096634A1 (en) | Use of clay mineral as a food additive and/or as supplementary food for aquatic organisms | |
CN111820338A (en) | Natural composite fish-hydrophilic aeromonas resisting agent, natural feed and preparation method thereof | |
Abdelhamid et al. | Effect of different sources and levels of some dietary biological additives on: I-growth performance and production economy of Nile tilapia fish | |
Gul et al. | Optimization of Selenium Inclusion Level in the Larval Diet of Labeo rohita | |
CN110679793A (en) | Artificial compound feed for preventing and/or improving white feces of penaeus vannamei boone and preparation method thereof | |
CN112136970A (en) | Piglet nursing compound feed and preparation method thereof | |
Hussain et al. | Evaluation of growth, nutrient absorption, body composition and blood indices under dietary exposure of iron oxide nanoparticles in Common carp (Cyprinus carpio) | |
AlMulhim et al. | Effect of incorporation of Spirulina platensis into fish diets, on growth performance and biochemical composition of Nile Tilapia, Oreochromis niloticus | |
CN110179006A (en) | The fowl dirty health care growth-promoting feedstuff additive of drop and its process | |
KR102376381B1 (en) | Agent for increasing useful bacteria in animal intestines, and method for improving intestinal environment in livestock in which said agent is used | |
KR20170062962A (en) | Composition of feed additive with probiotics | |
Manning et al. | Channel catfish, Ictalurus punctatus, fed diets containing aflatoxin from moldy corn do not experience increased mortality after challenge with Edwardsiella ictaluri | |
CN103005180A (en) | Selenium-rich prawn feed additive | |
CN113678762B (en) | Prevention and control method for skin rot of carnivorous fish | |
Islam et al. | Safety dose of three commercially used growth promoters: nuricell-aqua, hepaprotect-aqua and rapid-grow on growth and survival of Thai pangas (Pangasianodon hypophthalmus) | |
Patrachotpakinkul et al. | Effect of Trace Minerals Concentration on Growth Performance and Immune Response of White Shrimp (Litopenaeus vannamei) | |
CN116918913A (en) | Additive premix for improving intestinal health and immunity of cats and application of additive premix |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
AMND | Amendment | ||
E601 | Decision to refuse application | ||
J201 | Request for trial against refusal decision | ||
AMND | Amendment | ||
E801 | Decision on dismissal of amendment | ||
B601 | Maintenance of original decision after re-examination before a trial | ||
J301 | Trial decision |
Free format text: TRIAL DECISION FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 20070907 Effective date: 20080227 |
|
S901 | Examination by remand of revocation | ||
GRNO | Decision to grant (after opposition) | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20140320 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20140401 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20170512 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20180323 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20190401 Year of fee payment: 12 |